Get startedLog in
    Picture of Livanova logo

    LIVN — Livanova News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy

    Picture of Livanova logoLivanova
    07/05/2025 10:50
    May 7 (Reuters) - LivaNova PLC LIVN.O:

LIVANOVA ANNOUNCES 12-MONTH DATA FROM OSPREY CLINICAL STUDY FOR MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA, DEMONSTRATING STRONG RESPONSE AND DURABILITY OF THERAPY

LIVANOVA :  OVERALL RESPONDER RATE OF 65% , OVERALL REDUCTION IN MEDIAN APNEA-HYPOPNEA INDEX OF 68%

LIVANOVA : OVERALL REDUCTION IN MEDIAN OXYGEN DESATURATION INDEX OF 68%

Source text: ID:nBw9Pd9gSa

Further company coverage: LIVN.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Livanova

    See all news